← All companies

YDES

YD Bio Ltd

YDES Nasdaq Services-Medical Laboratories EDGAR ↗

$2.30

+0.10 +4.55%

Key statistics

from XBRL data in SEC filings

Market cap

$163M

Revenue (TTM)

$597K

Net income (TTM)

-$8.31M

EPS (TTM)

$-0.12

P/E ratio

—

Dividend yield

—

Free cash flow

-$8.04M

Cash

$6.01M

Total assets

$13.8M

Gross margin

28.1%

52-week range

$1.70 – $25.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K REPORT OF FOREIGN PRIVATE ISSUER May 1, 2026 20-F ANNUAL REPORT Apr 30, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Feb 26, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 30, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 21, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 16, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 15, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 6, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Nov 17, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Sep 30, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Sep 26, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Sep 19, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Aug 15, 2025

Other filings

4 Jul 1, 2026 4 Jul 1, 2026 EFFECT May 29, 2026 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 May 26, 2026 3/A Apr 20, 2026 4 Apr 2, 2026 4 Apr 2, 2026 3 Apr 2, 2026 3 Apr 2, 2026 3 Mar 30, 2026 3 Mar 27, 2026 3 Mar 26, 2026 3 Mar 18, 2026 424B3 PROSPECTUS SUPPLEMENT Feb 27, 2026 SCHEDULE 13G/A Feb 17, 2026 424B3 PROSPECTUS SUPPLEMENT Feb 5, 2026 S-8 REGISTRATION STATEMENT Jan 2, 2026 SCHEDULE 13G Dec 16, 2025 424B3 PROSPECTUS Nov 17, 2025 F-1/A AMENDMENT NO. 1 TO FORM F-1 Oct 24, 2025 UPLOAD Sep 29, 2025 F-1 REGISTRATION STATEMENT Sep 23, 2025 20FR12B REGISTRATION STATEMENT Sep 5, 2025 CERT Aug 28, 2025 8-A12B FOR REGISTRATION OF CERTAIN CLASSES Aug 20, 2025 EFFECT Jul 18, 2025 424B3 PROSPECTUS/PROXY Jul 18, 2025